The developer of a nasal spray is claiming that its anti-viral nasal spray may significantly reduce the infectivity of respiratory and cold viruses, including the CCP (Chinese Communist Party) virus. The data published data on July 27, by the Australian-based company Starpharma claims that its research at the Scripps Research Institute in the United States into astodrimer sodium (SPL7013) revealed the substance was able to inactivate over 99 percent of the CCP virus, including the Delta and Kappa variants. “We are very pleased to confirm the rapid virucidal activity of SPL7013, with greater than 99.99 percent reduction of infectious virus in just 30 seconds against the Delta variant,” Starpharma CEO Jackie Fairley said. “The Delta variant continues to challenge public health responses worldwide—most recently triggering lockdowns and emergency restrictions in Australia, Japan, and Indonesia.” The company also says its Viraleze nasal spray works against other viruses such as RSV, SARS, and MERS. Professor Philippe Gallay …